A very good video presentation by Dr. White of Berry Consultants. He walked us through the interpretation of the data and explained about the matched controls and how their estimates were on the conservative side.
My takeaway is in his conclusions where he mentions that our small sample size is encouraging in the sense of being either a Go or No-Go for progressing to a larger study. In my opinion all indicators point to full steam ahead.
The Interim results of Phase 2/3 should tell us whether MPL treatment at optimum dose will be successful or futile. My money is on success!
Ann: PharmAust's Phase 1 Study Data Presented at Major Conference, page-15
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $58.40K | 305.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 115000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 86074 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |